Status:
COMPLETED
Hyperoxia During Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?
Lead Sponsor:
Eastern Switzerland University of Applied Sciences
Collaborating Sponsors:
University Hospital, Zürich
Kantonsspital Winterthur KSW
Conditions:
Chronic Obstructive Pulmonary Disease
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic respiratory diseases are a global burden. Treatment options have improved in recent years, pulmonary rehabilitation plays a key role. Oxygen therapy is recommended in patients with a low satur...
Eligibility Criteria
Inclusion
- We will include male and female lung disease patients undergoing pulmonary rehabilitation: aged ≥ 18 years; stable condition \> 3 weeks (e.g. no exacerbations); resting oxygen saturation (SpO2) ≥ 88% and exercise induced hypoxemia defined by a fall in SpO2 by ≥ 4% during a 6-minute walking test (6MWT); informed consent as documented by signature.
Exclusion
- Severe daytime resting hypoxemia (SpO2 \< 88% or partial pressure of oxygen (PaO2) \< 8 kPa); unstable condition requiring adaptation of pharmacologic and other treatment modalities or requirement of intensive care or relevant severe concomitant disease; inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, neurological or orthopedic problems with walking disability or inability to ride a bicycle; women who are pregnant or breast feeding; enrolment in another clinical trial with active treatment.
Key Trial Info
Start Date :
January 24 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 17 2025
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT06174207
Start Date
January 24 2024
End Date
January 17 2025
Last Update
August 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonsspital Winterthur
Winterthur, Canton of Zurich, Switzerland, 8400